SARS-CoV-2-host cell surface interactions and potential antiviral therapies

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) utilizes its spike (S) protein to engage host cell surface receptors, primarily the human angiotensin-converting enzyme 2 (ACE2) receptor.
• The interaction between the SARS-CoV-2 S protein and ACE2 is a critical determinant of viral entry and subsequent infection.
• Understanding the molecular mechanisms of this interaction is crucial for developing effective antiviral strategies.

Purpose of the Study:

• To review the latest developments concerning the interface between SARS-CoV-2 and host cell surfaces.
• To evaluate current and potential mechanisms of viral binding, fusion, and S protein conformational changes upon interaction with ACE2.
• To provide insights into novel therapeutic approaches targeting viral proteins.

Main Methods:

• Review of existing literature on SARS-CoV-2-host cell interactions.
• Analysis of molecular mechanisms of S protein binding and conformational changes.
• Examination of therapeutic strategies targeting viral entry and non-structural proteins.

Main Results:

• The receptor binding domain (RBD) of the S protein forms hydrogen bonds with the ACE2 protease domain, inducing conformational changes.
• These surface interactions are key targets for antiviral therapies, including monoclonal antibodies.
• Novel therapies targeting viral non-structural proteins, such as remdesivir (an RNA polymerase inhibitor), are emerging.

Conclusions:

• Further elucidation of molecular interactions at the host cell surface is essential for advancing COVID-19 therapeutics.
• Targeting viral entry mechanisms and non-structural proteins offers promising avenues for developing more efficacious and selective treatments.
• Continued research into SARS-CoV-2-host cell dynamics will significantly contribute to reducing the global burden of COVID-19.